Latest "Bryn Aarflot AS (BAA)" News Stories

06:10 EDT 23rd October 2018 | BioPortfolio

Here are the most relevant search results for "Bryn Aarflot AS (BAA)" found in our extensive news archives from over 250 global news sources.

More Information about Bryn Aarflot AS (BAA) on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Bryn Aarflot AS (BAA) for you to read. Along with our medical data and news we also list Bryn Aarflot AS (BAA) Clinical Trials, which are updated daily. BioPortfolio also has a large database of Bryn Aarflot AS (BAA) Companies for you to search.

Showing "Bryn Aarflot" News Articles, all 6

Wednesday 3rd October 2018

Harpoon Therapeutics Announces Appointment of Natalie R. Sacks, M.D., as Chief Medical Officer

Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company developing a new class of T cell engaging therapeutics, announced today that it has appointed Natalie R. Sacks, M.D., as Chief Medical Officer. “We are thrilled to welcome Dr. Sacks as our new Chief Medical Offer. Natalie brings a strong record of accomplishment in the development and ...

Wednesday 19th September 2018

General David H. Petraeus Receives 2018 Soldier Citizen Award

BRYN MAWR, Pa., Sept. 19, 2018 /PRNewswire/ -- The American College of Financial Services presented the 2018 Soldier Citizen Award to General David H. Petraeus Read more...

Wednesday 5th September 2018

Nirag C. Jhala, M.D. is recognized by Continental Who's Who

BRYN MAWR, Pa., Sept. 5, 2018 /PRNewswire/ -- Nirag C. Jhala, M.D. is recognized by Continental Who's Who as a Pinnacle Lifetime Member in the Read more...

Thursday 16th August 2018

Main Line Health System Strategic SWOT Analysis Review [Report Updated: 19042018] Prices from USD $125

Main Line Health System Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.This uptotheminute company report will help you to formulate strategies to drive your busi...

Friday 6th July 2018

The Dermatologists at the Philadelphia Area’s Bryn Mawr Skin & Cancer Institute ...

BRYN MAWR, Pa., July 06, 2018 (GLOBE NEWSWIRE)

Saturday 28th April 2018

Bryn Mawr Trust Co Cuts Holdings in Amgen

BRYN MAWR TRUST Co lowered its holdings in shares of Amgen by 5.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 65,766 shares of the medical research company's stock after selling 3,577 shares during the period.

Quick Search


News Quicklinks